These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 10690822)
1. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis. Akpek EK; Hasiripi H; Christen WG; Kalayci D Ophthalmology; 2000 Feb; 107(2):263-9. PubMed ID: 10690822 [TBL] [Abstract][Full Text] [Related]
2. Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study. Jain AK; Sukhija J Indian J Ophthalmol; 2006 Jun; 54(2):111-6. PubMed ID: 16770028 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topical azelastine compared with topical mitomycin C in patients with allergic conjunctivitis. Sodhi PK; Pandey RM; Ratan SK Cornea; 2003 Apr; 22(3):210-3. PubMed ID: 12658084 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Santos CI; Huang AJ; Abelson MB; Foster CS; Friedlaender M; McCulley JP Am J Ophthalmol; 1994 Apr; 117(4):488-97. PubMed ID: 8154531 [TBL] [Abstract][Full Text] [Related]
7. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Kiliç A; Gürler B Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949 [TBL] [Abstract][Full Text] [Related]
8. Vernal keratoconjunctivitis in Thailand. Kosrirukvongs P; Vichyanond P; Wongsawad W Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Caldwell DR; Verin P; Hartwich-Young R; Meyer SM; Drake MM Am J Ophthalmol; 1992 Jun; 113(6):632-7. PubMed ID: 1598953 [TBL] [Abstract][Full Text] [Related]
10. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis. Sharma A; Gupta R; Ram J; Gupta A Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021 [TBL] [Abstract][Full Text] [Related]
11. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis. Kosrirukvongs P; Luengchaichawange C J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis]. Hida WT; Nogueira DC; Schaefer A; Dantas PE; Dantas MC Arq Bras Oftalmol; 2006; 69(6):851-6. PubMed ID: 17273679 [TBL] [Abstract][Full Text] [Related]
13. A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone-like papillae in severe atopic and vernal keratoconjunctivitis. Tanaka M; Takano Y; Dogru M; Fukagawa K; Asano-Kato N; Tsubota K; Fujishima H Cornea; 2004 May; 23(4):326-9. PubMed ID: 15097124 [TBL] [Abstract][Full Text] [Related]
14. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889 [TBL] [Abstract][Full Text] [Related]
15. Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis. Verin PH; Dicker ID; Mortemousque B Clin Exp Allergy; 1999 Apr; 29(4):529-36. PubMed ID: 10202368 [TBL] [Abstract][Full Text] [Related]
16. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Demirci H; McCormick SA; Finger PT Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099 [TBL] [Abstract][Full Text] [Related]